The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules for over-the-counter treatment of frequent heartburn., according to a company press release.
Approximately 70% smaller than the standard tablet version of omeprazole currently available, the “first-to-market” miniature capsule is intended to “provide a differentiated and preferred product offering for consumers,” noted the press release.
“This approval illustrates Perrigo’s research and development and regulatory expertise and our continued